Exploring the characteristics of suboptimally controlled patients after 24 weeks of basal insulin treatment: An individualized approach to intensification
Post hoc analysis of patients with type 2 diabetes who started insulin detemir. HbA1c ⩾ 7.0% is associated with baseline parameters related to disease severity. Supports intensive titration/treatment intensification in subjects with HbA1c ⩾ 7.0%.